New York State Teachers Retirement System Purchases Shares of 43,401 Astrana Health, Inc. (NASDAQ:ASTH)

New York State Teachers Retirement System purchased a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 43,401 shares of the company’s stock, valued at approximately $2,515,000. New York State Teachers Retirement System owned about 0.08% of Astrana Health at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of ASTH. GAMMA Investing LLC purchased a new stake in shares of Astrana Health during the 3rd quarter worth about $34,000. Nisa Investment Advisors LLC purchased a new stake in Astrana Health during the third quarter worth approximately $35,000. Central Pacific Bank Trust Division acquired a new stake in shares of Astrana Health in the third quarter worth $160,000. Everence Capital Management Inc. purchased a new position in shares of Astrana Health in the 3rd quarter valued at $272,000. Finally, Granite Bay Wealth Management LLC acquired a new position in shares of Astrana Health during the 3rd quarter valued at $290,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Stock Performance

Astrana Health stock opened at $59.08 on Friday. Astrana Health, Inc. has a 52 week low of $29.63 and a 52 week high of $63.20. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.62. The stock has a market cap of $2.90 billion, a P/E ratio of 41.03, a price-to-earnings-growth ratio of 2.07 and a beta of 1.24. The stock has a 50 day moving average of $55.53 and a 200-day moving average of $47.40.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. The firm had revenue of $486.30 million for the quarter, compared to the consensus estimate of $440.68 million. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The firm’s revenue was up 39.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.28 EPS. On average, analysts expect that Astrana Health, Inc. will post 1.31 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on the company. TD Cowen assumed coverage on Astrana Health in a report on Monday, October 14th. They issued a “buy” rating and a $66.00 price target for the company. Robert W. Baird raised their target price on Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a report on Thursday, August 15th. Truist Financial increased their price objective on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research report on Friday, August 9th. BTIG Research boosted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Finally, Stifel Nicolaus upped their target price on shares of Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $62.00.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.